by Benjamin Boettner, Harvard University The Wyss Institute’s eRapid electrochemical sensor platform enables the multiplexed, fast, and inexpensive detection of biomarker molecules specific for infectious and other diseases at the point-of-care. Credit: Wyss Institute at Harvard University Not all SARS-CoV-2 infections are created equal. We have learned this through multiple virus waves are taking their...
